Clinical Trials
3 trialsNCT07296484 2026-05-12
CAPTAIN-T2D
Sparrow Pharmaceuticals
Phase 2 Recruiting
NCT07104812 2026-02-11
Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)
Mayo Clinic
Phase 2 Recruiting
NCT06246357 2025-12-09
Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting